Drug
Anastrozole (Arimidex)
Anastrozole (Arimidex) is a pharmaceutical drug with 6 clinical trials. Historical success rate of 80.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Terminated
1(17%)
Phase Distribution
Ph phase_2
3
50%
Ph not_applicable
1
17%
Ph phase_1
1
17%
Ph phase_3
1
17%
Phase Distribution
1
Early Stage
3
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
1(16.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(4)
Terminated(1)
Detailed Status
Completed4
Not yet recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (16.7%)
Phase 23 (50.0%)
Phase 31 (16.7%)
N/A1 (16.7%)
Trials by Status
not_yet_recruiting117%
completed467%
terminated117%
Recent Activity
0 active trials
Showing 5 of 6
not_yet_recruitingnot_applicable
The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans
NCT07212712
completedphase_2
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
NCT00186121
terminatedphase_2
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
NCT00932152
completedphase_2
Open Label Arimidex in Gynecomastia
NCT00241436
completedphase_1
Anastrozole 1 mg Tablets Under Fasting Conditions
NCT01182181
Clinical Trials (6)
Showing 6 of 6 trials
NCT07212712Not Applicable
The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans
NCT00186121Phase 2
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
NCT00932152Phase 2
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
NCT00241436Phase 2
Open Label Arimidex in Gynecomastia
NCT01182181Phase 1
Anastrozole 1 mg Tablets Under Fasting Conditions
NCT00814125Phase 3
ATAC - Endometrial Sub-Protocol
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6